ESC 365 - Antiplatelet effects of intraoperative administration of ticagrelor versus clopidogrel in patients undergoing one-stop hybrid coronary revascularization: a single-center randomized controlled trial

ESC Premium Access

Antiplatelet effects of intraoperative administration of ticagrelor versus clopidogrel in patients undergoing one-stop hybrid coronary revascularization: a single-center randomized controlled trial

Session: Poster Session 6 - Treatment of coronary artery disease, other

Topic: Treatment

Speaker: Doctor Q. Zhang (Beijing, CN)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Qian Zhang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

0 follower

4 more presentations in this session

Predictors of the risk of recurrent cardiovascular events in patients with unstable angina with conservative treatment strategy

Speaker: Doctor I. Lazareva (Minsk, BY)

Features of treatment and outcomes in elderly patients. Results of the kracs register

Speaker: Miss S. Kruchinova (Krasnodar, RU)

Predictors of 10-year mortality and re-intervention in patients with multivessel coronary disease, reduced systolic left ventricular function, after complete revascularization by PCI or CABG

Speaker: Doctor T. Popov (Sremska Kamenica, RS)

The benefit of one week immersion in lifestyle-based program for sustainable improvements in cardiovascular risk factors over time

Speaker: Doctor M. Aggarwal (Gainesville, US)

Access the full session

Poster Session 6 - Treatment of coronary artery disease, other

Speakers: Doctor Q. Zhang, Doctor I. Lazareva, Miss S. Kruchinova, Doctor T. Popov, Doctor M. Aggarwal

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources